Contribution of Lp(a) to the Occurrence of Vascular Diseases:Correlation of Several Risk Factors Including Diabetes Mellitus
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-04-01
著者
-
MATSUZAWA Yuji
Second Department of Internal Medicine, Osaka University Medical School
-
Kubo Masaharu
Second Department of Internal Medicine osaka University School of Medicine
-
Matsuzawa Yuji
Second Department Of Internal Medicine Osaka University Medical School
-
Kubo Masaharu
Second Department Of Internal Medicine Osaka University Medical School
-
TAKAMI Shigeki
Second Department of Internal Medicine,Osaka University Medical School
-
Takami Shigeki
Second Department Of Internal Medicine Osaka University Medical School
関連論文
- Clinical Effects of Rosuvastatin, a New HMG-CoA Reductase Inhibitor, in Japanese Patients With Primary Hypercholesterolemia : an Early Phase II Study
- A Case with Prolactinoma Treated with Pergolide and Its Histology
- Histopathologic Study of the Pancreas Shows a Characteristic Lymphocytic Infiltration in Japanese Patients with IDDM
- Proliferation and differentiation of pancreatic β-cells: ultrastructural analysis of the pancreas in diabetic mice induced by selective alloxan perfusion
- High-performance liquid chromatographic assay for farnesyl-protein transferase activity with dabsylated peptide
- Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
- Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum γ-glutamyltranspeptidase levels
- Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
- Effects of erythromycin in chronic idiopathic intestinal pseudo-obstruction
- Molecular Disorders of Cholesteryl Ester Transfer Protein
- CHARACTERISTICS OF CORONARY HEART DISEASE (CHD) IN FIMILIAL HYPERCHOLESTEROLEMIA (FH) AND ITS INCIDENCE IN FH WITHOUT CLINICAL CARDIAC SYMPTOM : Atherosclerosis : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Peroxisome Proliferator-activated Receptor γ Induces Growth Arrest and Differentiation Markers of Human Colon Cancer Cells
- COMPARISON OF PROGNOSIS BETWEEN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH INTENSIVE TREATMENT AND THOSE WITHOUT TREATMENT : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Society
- -531- STUDIES ON CLINICAL AND BIOCHEMICAL FACTORS WHICH AFFECT THE OCCURRENCE OF CORONARY ARTERY DISEASE (CAD) IN FAMILIAL HYPERCHOLESTEROLEMIA (FH) : INVESTIGATION IN THREE PAIRS OF SIBLINGS
- ANALYSIS OF CHEST X-RAY FILM AND ELECTROCARDIOGRAM IN OBSES PATIENTS : Exercise Test (II) : FREE COMMUNICATIONS (VI) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS OF CORONARY ARTERY DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA : Ischemic Heart Disease (VI) : FREE COMMUNICATIONS (VI) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- -252- LIPOPROTEIN ABNORMALITIES IN FAMILIAL HYPERALPHALIPOPROTEINEMIA WITH SPECIAL REFERENCE TO CORONARY HEART DISEASE : Ischemic Heart Diseases : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCI
- LIPOPROTEIN ABNORMALITIES IN FAMILIAL HYPERALPHALIPOPROTEINEMIA ASSOCIATED WITH CORNEAL OPACIFICATION AND CORONARY HEART DISEASE : Atherosclerosis : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- LIPOPROTElN METABOLISM IN HYPER-ALPHA-LIPOPROTEINEMIA WITH DEFICIENCY OF CHOLESTERYL ESTER TRANSFER PROTEIN : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Society
- SIGNIFICANCE OF COMBINED TREATMENT WITH PRAVASTATIN, PROBUCOL, AND CHOLESTYLAMINE FOR CHOLESTEROL REDUCTION AND XANTHOMA REGRESSION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Soci
- Contribution of Lp(a) to the Occurrence of Vascular Diseases:Correlation of Several Risk Factors Including Diabetes Mellitus
- Group II phospholipase A2 is not a major modifier of colonic adenomatous polyps in humans